Yanling Lin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Reproductive Medicine top 10%
Papers in
-
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Qingping He (4 shared papers)Marla J. Berry (3 shared papers)Yukiko Yamazaki (3 shared papers)Miyuki Yamamoto (3 shared papers)Longmei Cai (10 shared papers)Xiaohan Zhou (7 shared papers)Yu Hong (1 shared paper)Yuhua Tong (1 shared paper)
- Journals
- Biology of Reproduction (3 papers)Phytotherapy Research (2 papers)Scientific Reports (2 papers)Antioxidants (2 papers)International Journal of Biological Macromolecules (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yanling Lin
60 papers receiving 1.1k citations
Yanling Lin's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 143
- Reproductive Medicine 61
- Nutrition and Dietetics 100
- Molecular Biology 380
- Toxicology 18
Countries citing papers authored by Yanling Lin
This map shows the geographic impact of Yanling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Lin more than expected).
Fields of papers citing papers by Yanling Lin
This network shows the impact of papers produced by Yanling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Lin. The network helps show where Yanling Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Platinum Nanoparticles Regulated V2C MXene Nanoplatforms with NIR‐II Enhanced Nanozyme Effect for Photothermal and Chemodynamic Anti‐Infective Therapy Hit paper breakdown → | 2024 | 121 |
| 2 | 2008 | 103 | |
| 3 | 2010 | 76 | |
| 4 | 2006 | 73 | |
| 5 | 2013 | 48 | |
| 6 | 2019 | 39 | |
| 7 | 2010 | 37 | |
| 8 | 2019 | 35 | |
| 9 | 2010 | 33 | |
| 10 | 2020 | 31 | |
| 11 | 2024 | 30 | |
| 12 | 2019 | 30 | |
| 13 | 2022 | 27 | |
| 14 | 2021 | 25 | |
| 15 | 2013 | 25 | |
| 16 | 2014 | 23 | |
| 17 | 2012 | 21 | |
| 18 | 2020 | 21 | |
| 19 | 2008 | 18 | |
| 20 | 2022 | 17 |
About Yanling Lin
Yanling Lin is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Plant Science, having authored 62 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers), Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Endometriosis Research and Treatment (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Cancer Research (143 citations), Reproductive Medicine (61 citations), Nutrition and Dietetics (100 citations), Molecular Biology (380 citations) and Toxicology (18 citations). Yanling Lin has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qingping He, Marla J. Berry, Yukiko Yamazaki, Miyuki Yamamoto, Longmei Cai, Xiaohan Zhou, Yu Hong, Yuhua Tong, Chunwu Zhang and Marianna Murányi. Their work appears in journals such as Biology of Reproduction, Phytotherapy Research, Scientific Reports, Antioxidants and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.